Branched Stent Graft Market

Branched Stent Graft Market Outlook (2022 to 2032)

Newly-released Branched Stent Graft Market industry analysis report by Future Market Insights shows that global sales of the Branched Stent Graft Market in 2021 were held at USD 335.8 Million. With a CAGR of 8.5% from 2022 to 2032, the market is projected to reach a valuation of USD 814 Million by 2032. The market is projected to witness the largest revenue through the ChiMillioney application which is expected to grow at a CAGR of 9.3% from 2022 to 2032.

Attribute	Details
Global Branched Stent Graft Market (2022)	USD 361 Million
Global Branched Stent Graft Market (2032)	USD 814 Million
Global Branched Stent Graft Market CAGR (2022 to 2032)	8.5%
USA Branched Stent Graft Market (2022)	7.6%
Key Companies Profiled	Medtronic; Biotronik; Alvimedica; Endocor GmbH; Eucatech AG; Merit Medical Systems; Abbott; Cook Medical; Cardinal Health; Boston Scientific Corp.; Terumo Corp.

Revenue of Branched Stent Graft Market from 2017 to 2021 Compared to Demand Outlook for 2022 to 2032

As per the Branched Stent Graft Market industry research by Future Market Insights - a market research and competitive intelligence provider, historically, from 2017 to 2021, the market value increased at around 7.1% CAGR, wherein, countries such as the USA, UK, China, Japan, and South Korea held a significant share in the global market.

The global branched stent grafts are used in a variety of EVAR (endovascular aneurysm repair) operations. Because of lower rates of morbidity and mortality, EVAR for significant aortic diseases such as aneurysms, traumatic ruptures, and dissections has acquired universal surgeon and patient acceptability. Over the forecast period, this trend is expected to fuel the demand in the global branching stent grafts market. The global branching stent grafts market is also growing due to rising cases of cardiovascular illnesses and the wider acceptance of stenting operations.

What are the complications present in the implantation of a Stent Graft?

The placement of a stent graft within the human vasculature is a minimally invasive surgery used to treat aortic aneurysms and dissections. After a pigtail catheter and guide wires are inserted, a shaft catheter with a foldable stent or stent graft is used to cover the lesion.

The physician must check that the stent graft is properly positioned inside the vascular tree before unfolding it. Misplacements of covered stent grafts might result in a partial or complete cut-off of blood flow to crucial organs. An endoleak is a serious complication that occurs when blood leaks between the stent graft and the aneurysm sac.

How are the aortic aneurysms contributing to the growth of the Branched Stent Graft Market?

The prevalence of aortic aneurysms is predicted to rise as the global old population grows, contributing to market growth throughout the forecast period. Aortic aneurysms were the main cause of mortality in the USA in 2018, accounting for 9,923 deaths. Aortic aneurysms include thoracic and abdominal aortic aneurysms, as well as aneurysms in other areas of the body.

Medtronic is a medical device manufacturer that specializes in stent grafts. A recently approved stent graft apparatus allows researchers to study using endograft for fenestrated aneurysm repair for patients suffering from a type of abdominal aortic aneurysm located close to the organ those branches off to the internal organs. For patients who lack the proximity necessary for conventional endovascular aneurysm repair, a fenestrated endograft is used.

Which Region is projected to offer the most promising opportunity for Branched Stent Graft Market?

With a CAGR of more than 10% over the projection period, the market in Asia Pacific is expected to grow at the fastest pace. This expansion might be attributed to growing healthcare spending and the rapidly expanding medical tourism industry in the Asia Pacific area. Developing economies such as China, Japan, India, and Australia make up the APAC regional market. The presence of higher-quality healthcare infrastructure, convenience, and cheap treatment alternatives in these nations is also likely to drive regional market expansion.

What is the scope of growth of the Branched Stent Graft Market in North America?

Because of its well-established healthcare infrastructure, presence of multiple competitors, and favorable reimbursement coverage, North America is expected to hold the greatest share of the worldwide branching stent grafts market in the future years. Because of the strong presence of numerous established and well-trained industry competitors, it is expected that the global branching stent grafts market in North America will face tough rivalry in the future years.

Country-wise Analysis

USA Branched Stent Graft Market Analysis

By 2021, the USA will continue to account for the largest share of the global branching stent grafts market, however, there are worries about device availability, particularly in addressing difficult indications. The market in the country is projected to reach USD 320 Million by 2032. Numerous devices that are currently approved in other countries, such as fenestrated stent grafts, are currently being administered in medical trials in the USA, disallowing medical practitioners from using systems that have a broad scope of applications.

UK Branched Stent Graft Market Analysis

The market in the UK is projected to reach a valuation of USD 37 Million by 2032. Growing at a CAGR of 11.1% from 2022 to 2032, the market is expected to gross an absolute dollar opportunity of USD 24 Million.

Japan Branched Stent Graft Market Analysis

In Japan, the market is expected to reach USD 29.2 Million by 2032. Growing at a CAGR of 9.4%, the market is projected to garner an absolute dollar opportunity of USD 17.4% during the forecast period.

South Korea Branched Stent Graft Market Analysis

The market in South Korea is projected to register USD 14.4 Million by 2032, growing at a CAGR of 10.1% from 2022 to 2032. During the forecast period, the market is expected to gross an absolute dollar opportunity of USD 8.8 Million.

Category-wise Insights

Which application is expected to grow the fastest in the Branched Stent Graft Market?

Branched stent grafts are commonly used in EVAR treatments. EVAR is divided into the chimney, Fenestrated Endovascular Aortic Aneurysm Repair (FEVAR), and various sub-categories. Recent advancements in branched stent grafts have made it possible to treat a variety of aortic aneurysms, including those involving the visceral arteries.

Competitive Analysis

Some of the key players in the branched stent graft market include Medtronic, Biotronik, Alvimedica, Endocor GmbH, Eucatech AG, Merit Medical Systems, Abbott, Cook Medical, Cardinal Health, Boston Scientific Corp., and Terumo Corp.

Some of the recent developments of key players in the Branched Stent Graft Market are as follows:

• In March 2021, the Zenith Fenestrated + Endovascular Graft (ZFEN+) obtained Breakthrough Device Designation from the USA FDA.
• In December 2020, the mid-term results of Terumo's RELAY PLUS thoracic stent graft system were disclosed. The goal of this study was to report on real-world outcomes of TEVAR patients in the USA.
• In March 2021, Medtronic partnered with Spectrum Health to increase healthcare value and enhance patient outcomes in West Michigan.

Similarly, recent developments related to companies offering Branched Stent Graft have been tracked by the team at Future Market Insights, which are available in the full report.

Market Segments Covered in Branched Stent Graft Industry Analysis

Application Outlook:

• FEVAR
• Chimney
• Other EVARs

Type Outlook:

• Iliac Stent
• Other Types

Regional Outlook:

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East and Africa (MEA)

Frequently Asked Questions

What is the current worth of the Branched Stent Graft Market?

The global market is worth more than USD 361.3 Million at present.

What is the sales forecast for Branched Stent Graft Market?

The market value is projected to increase at a CAGR of around 8.5% from 2022 to 2032.

What was the last 5 year’s market CAGR?

The market value increased at a CAGR of around 7.1% from 2017 to 2021.

At what CAGR is the demand for Branched Stent Graft Expected to Increase in the Next 10 Years?

With a projected CAGR of 8.7% during the forecast period, the Iliac Stent segment dominated the Branched Stent Graft industry.

Which are the top countries driving demand for Branched Stent Graft Market?

The top 5 countries driving demand for Branched Stent Graft Market are the USA, UK, China, Japan, and South Korea.

What is the outlook for the market in North America?

Because of its well-established healthcare infrastructure, presence of multiple major competitors, and favorable reimbursement coverage, North America is expected to hold the greatest share of the global branching stent grafts market in the future years

At what percentage is the revenue of Branched Stent Graft Market going to register growth in UK?

The UK market for Branched Stent Grafts is projected to expand at a CAGR of around 11.1% from 2022 to 2032.

What do statistics for South Korea and Japan reveal?

While the market in South Korea is expected to grow at nearly 10.1%, the market in Japan is projected to register a CAGR of nearly 9.4% from 2022 to 2032.